Table 3.
Parameter | n (%) |
---|---|
Underwent SLNB | 3156 (79.6) |
Did not undergo SLNB | 1200 (20.4) |
SLNB− | 3000 (95.1) |
SLNB+ | 153 (4.9) |
Not reported | 3 (<0.1) |
Micrometastases | 66 (43.1) |
Macrometastases | 47 (30.7) |
Not reported | 40 (26.1) |
ITCs | 26 (0.8) |
ALND | 148 (4.7) |
SLNB, sentinel lymph node biopsy; ITCs, isolated tumour cells; ALND, axillary lymph node dissection.